Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Radio Frequency (RF) Analog Research Engineer Location : Martigny, Switzerland Company Overview: INAUTALENT is supporting the International Space Federation (ISF), a pioneering R&D organization based in Cluses (French Alps), in strengthening its team in Switzerland. ISF